All In MedTech

Device Trial Radar · NCT07512206

AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease

AERO CAD: A Prospective, Multi-Center, Single-Arm Study Evaluating the Shockwave C2 Aero Coronary IVL System in Calcified Coronary Artery Disease

Last checked: Nov 19, 2026Latest source record: Apr 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Apr 1, 2026

Primary completion

Oct 1, 2026

Study completion Dec 1, 2026

Sponsor

Lead sponsor
OPCI Core Laboratories LLCAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 6, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The AERO CAD study is a prospective, multi-center, single-arm, post-market clinical investigation evaluating the procedural performance and clinical outcomes of the Shockwave C2 Aero Coronary Intravascular Lithotripsy (IVL) System in patients with calcified coronary artery disease undergoing percutaneous coronary intervention (PCI). The study will enroll up to 200 subjects across up to 8 U.S. sites. The primary objective is to generate real-world evidence on device performance and clinical outcomes, including target lesion failure at 30 days and procedural success.

Conditions

  • Coronary Artery Disease (CAD)
  • Coronary Calcification
  • Coronary Calcified Disease
  • Coronary Calcified Nodules

Interventions

  • Shockwave C2 Aero Coronary IVL SystemDevice

    Participants undergoing PCI with coronary IVL using the Shockwave C2 Aero system followed by stent placement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Target Lesion Failure (TLF)Time frame: 30 days
  2. Procedural SuccessTime frame: During procedure / during hospitalization (up to 5 days)

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Los Robles Regional Medical Center

    Thousand Oaks, California

  • Henry Ford St. John Hospital

    Detroit, Michigan

  • Jersey Shore University Medical Center

    Neptune City, New Jersey

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.